ZEGA Investments LLC Takes Position in Lam Research Corporation $LRCX

ZEGA Investments LLC acquired a new position in shares of Lam Research Corporation (NASDAQ:LRCXFree Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 8,765 shares of the semiconductor company’s stock, valued at approximately $1,174,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. IMG Wealth Management Inc. acquired a new position in shares of Lam Research during the 2nd quarter valued at about $26,000. Howard Hughes Medical Institute acquired a new stake in Lam Research during the second quarter worth about $27,000. Strategic Wealth Investment Group LLC purchased a new position in Lam Research during the second quarter worth about $29,000. Delos Wealth Advisors LLC acquired a new position in Lam Research in the 2nd quarter valued at about $30,000. Finally, REAP Financial Group LLC purchased a new stake in shares of Lam Research in the 2nd quarter valued at approximately $31,000. Institutional investors and hedge funds own 84.61% of the company’s stock.

Key Headlines Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

  • Positive Sentiment: Bank of America raised its price target on LRCX from $195 to $245 and reiterated a “buy” rating—this upgrade is a clear near-term catalyst supporting higher shares. Benzinga
  • Positive Sentiment: Analysts expect double-digit earnings growth for Lam’s upcoming Q2 report, reinforcing expectations of improving profitability as the semiconductor cycle strengthens; a beat would likely sustain the rally. What to Expect From Lam Research’s Q2 2025 Earnings Report
  • Positive Sentiment: Industry-focused coverage outlines several drivers that could keep LRCX shares higher (cycle recovery, secular demand for advanced nodes, strong margin leverage), backing bullish sentiment among investors. What Could Keep Driving Lam Research Stock Higher?
  • Neutral Sentiment: Jim Cramer said LRCX “needs to put up plants,” highlighting the potential need for higher capex and capacity expansion—this underscores long-term opportunity but also signals near-term capital intensity that investors should monitor. Lam Research (LRCX) Needs to “Put Up Plants,” Says Jim Cramer
  • Neutral Sentiment: Reported short-interest data for January appears anomalous (zeros/NaN and a 0.0 days-to-cover); current figures suggest no meaningful short-pressure signal, but verify with official exchange data before drawing conclusions.
  • Neutral Sentiment: Coverage noting Lam as a top 2025 performer highlights momentum but is more descriptive than a fresh catalyst—useful context for sentiment but less likely to move the stock by itself. 2 Tech Stocks That Beat the Mag Seven By a Mile in 2025—Can They Repeat?

Insider Transactions at Lam Research

In other news, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction dated Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the transaction, the chief financial officer owned 987,237 shares in the company, valued at approximately $148,677,892.20. This represents a 3.90% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Ava Harter sold 9,010 shares of the firm’s stock in a transaction dated Monday, October 27th. The stock was sold at an average price of $157.47, for a total value of $1,418,804.70. Following the sale, the insider directly owned 56,786 shares in the company, valued at $8,942,091.42. This trade represents a 13.69% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 50,418 shares of company stock valued at $7,667,305. Insiders own 0.31% of the company’s stock.

Lam Research Price Performance

Lam Research stock opened at $220.40 on Tuesday. The company’s 50 day moving average is $167.18 and its two-hundred day moving average is $134.20. The firm has a market cap of $276.83 billion, a PE ratio of 48.55, a price-to-earnings-growth ratio of 2.52 and a beta of 1.77. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $222.58.

Lam Research (NASDAQ:LRCXGet Free Report) last released its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The firm had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.23 billion. During the same period last year, the business posted $0.86 earnings per share. Lam Research’s revenue was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, research analysts expect that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd were issued a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Wednesday, December 3rd. Lam Research’s dividend payout ratio (DPR) is presently 22.91%.

Analyst Ratings Changes

Several analysts have recently commented on LRCX shares. HSBC set a $127.00 price target on shares of Lam Research and gave the company a “hold” rating in a research report on Tuesday, September 30th. BNP Paribas Exane upped their price target on Lam Research from $80.00 to $140.00 and gave the company a “neutral” rating in a research note on Thursday, October 23rd. Cowen reissued a “buy” rating on shares of Lam Research in a research report on Thursday, October 23rd. Deutsche Bank Aktiengesellschaft upped their target price on shares of Lam Research from $160.00 to $195.00 and gave the company a “buy” rating in a research report on Friday, December 19th. Finally, Hsbc Global Res upgraded shares of Lam Research to a “hold” rating in a research report on Tuesday, September 30th. Twenty-six investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $172.87.

View Our Latest Stock Analysis on Lam Research

Lam Research Profile

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Featured Articles

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.